[Carbon ion radiotherapy for brain tumors]. 2005

Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
Hospital, Research Center for Charged Particle Therapy, National Institute for Radiological Sciences.

UI MeSH Term Description Entries
D010315 Particle Accelerators Devices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy. Betatrons,Linear Accelerators,Accelerator, Linear,Accelerator, Particle,Accelerators, Linear,Accelerators, Particle,Betatron,Linear Accelerator,Particle Accelerator
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002244 Carbon A nonmetallic element with atomic symbol C, atomic number 6, and atomic weight [12.0096; 12.0116]. It may occur as several different allotropes including DIAMOND; CHARCOAL; and GRAPHITE; and as SOOT from incompletely burned fuel. Carbon-12,Vitreous Carbon,Carbon 12,Carbon, Vitreous
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019583 Dose Fractionation, Radiation Administration of the total dose of radiation (RADIATION DOSAGE) in parts, at timed intervals. Radiotherapy Dose Fractionation,Dose Fractionation, Radiotherapy,Radiation Dose Fractionation,Dose Fractionations, Radiotherapy,Fractionation, Radiation Dose,Fractionation, Radiotherapy Dose,Fractionations, Radiotherapy Dose,Radiotherapy Dose Fractionations
D020266 Radiotherapy, Conformal A therapy using IONIZING RADIATION where there is improved dose homogeneity within the tumor and reduced dosage to uninvolved structures. The precise shaping of dose distribution is achieved via the use of computer-controlled multileaf collimators. Conformal Radiotherapy,3-D Conformal Radiotherapy,Three-Dimensional Conformal Radiotherapy,3-D Conformal Radiotherapies,Conformal Radiotherapies,Conformal Radiotherapies, 3-D,Conformal Radiotherapies, Three-Dimensional,Conformal Radiotherapy, 3-D,Conformal Radiotherapy, Three-Dimensional,Radiotherapies, 3-D Conformal,Radiotherapies, Conformal,Radiotherapies, Three-Dimensional Conformal,Radiotherapy, 3-D Conformal,Radiotherapy, Three-Dimensional Conformal,Three Dimensional Conformal Radiotherapy,Three-Dimensional Conformal Radiotherapies
D063193 Heavy Ion Radiotherapy The use of a heavy ion particle beam for radiotherapy, such as the HEAVY IONS of CARBON. Carbon Ion Radiation Therapy,Carbon Ion Radiotherapy,Carbon Ion Therapy,Heavy Ion Radiation Therapy,Heavy Ion Therapy,Carbon Ion Therapies,Heavy Ion Radiotherapies,Heavy Ion Therapies,Radiotherapies, Heavy Ion,Radiotherapy, Carbon Ion,Radiotherapy, Heavy Ion,Therapies, Carbon Ion,Therapies, Heavy Ion,Therapy, Carbon Ion,Therapy, Heavy Ion

Related Publications

Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
April 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
October 2013, Acta oncologica (Stockholm, Sweden),
Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
November 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
April 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
January 2014, Case reports in otolaryngology,
Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
January 2016, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology,
Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
May 2016, Nihon rinsho. Japanese journal of clinical medicine,
Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
January 1994, CA: a cancer journal for clinicians,
Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
September 2000, Current oncology reports,
Jun-Etsu Mizoe, and Hirohiko Tsujii, and Tsuyoshi Yanagi, and Azusa Hasegawa, and Ryo Takagi
January 2021, Journal of the anus, rectum and colon,
Copied contents to your clipboard!